Drugs Behaviour, And Society 2nd Canadian Edition by Carl L Hart -Test Bank

 

To Purchase this Complete Test Bank with Answers Click the link Below

 

https://tbzuiqe.com/product/drugs-behaviour-and-society-2nd-canadian-edition-by-carl-l-hart-test-bank/

 

If face any problem or Further information contact us At tbzuiqe@gmail.com

 

 

 

Sample Test

Chapter 03

Drug Policy

 

 

Multiple Choice Questions

1.   Recently, patients that are being seen at the Centre for Pain Management in Halifax were being asked to do which of the following, in what some patients felt was against their rights?
A.Subject to a blood test.
B. Subject to a urinary toxicology.
C. Provide weekly sexual histories.
D. Provide DNA samples to the local police enforcement agency.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

2.   Although prior to 1908, opium was not viewed as a serious societal threat, which of the following was viewed to be a problematic health concern in Canada?
A.Alcohol and cocaine
B. Cocaine and tobacco
C. Heroin and cocaine
D. Tobacco and alcohol

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

 

 

3.   From the mid to late 1800s the Canadian government’s primary financial concern was regarding which of the following?
A.Alcohol
B. Marijuana
C. Barbiturates
D. Opium

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

4.   In 1908, the Opium Act was enacted. Which of the following Canadian(s) initiated this legislation?
A.Dr. Le Dain
B. Mackenzie King
C. Euro-Canadian Society
D. Emily Murphy

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

5.   In 1908, the Opium Act made it illegal to import, manufacture, sell or possess opium for nonmedical purposes. What prompted this action to be taken?
A.The smoking of opium would lead to high rates of lung cancer.
B. Opium use would outstrip the use of alcohol.
C. Smoking opium would corrupt the youth of the nation.
D. An increasing number of white people were smoking opium.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

 

 

6.   In the early 1900s in Canada, what were the fears regarding opium connected to?
A.Large numbers of drug-related deaths
B. Family violence
C. Racial dislike against Chinese immigrants
D. Public use in saloons and night clubs

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

7.   Which of the following was the first step toward federal drug regulation in Canada?
A.Controlled Substances Act
B. Pure Food and Drugs Act
C. Prescription Drug Act
D. Patent Medicine Act

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

8.   Which of the following describes the order in which Canada’s drug legislation unfolded?
A.Opium Act; Opium and Drug Act; Narcotic Control Act; Patent Medicine Act
B. Opium Act; Opium and Drug Act; Patent Medicine Act; Food and Drugs Act
C. Opium Act; Patent Medicine Act; Opium and Drug Act; Narcotic Control Act
D. Opium Act; Patent Medicine Act, Opium and Drug Act; Prescription Drug Act

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

 

 

9.   In 1955, the Senate Special Committee on the Traffic of Narcotics in Canada was formed in response to the medical community’s approach to drug addiction as a medical and social problem rather than as a criminal issue. What did committee’s work result in?
A.A more compassionate view of addiction among members of the general public in Canada.
B. Pressure on law enforcement to be more tolerant of addiction.
C. The committee siding with law enforcement and enacting the Narcotic Control Act.
D. The committee being tied between members who wanted a medical model and those who did not.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

10.                Between 1969 and 1973, the Le Dain Commission produced four reports that recommended all of the following EXCEPT which one?
A.The gradual withdrawal of criminalization of illegal drugs.
B. That the possession of cannabis not be a crime.
C. The abolishment of imprisonment for possession of drugs.
D. Regulatory standards for the production and distribution of cocaine.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

11.                Under the CSDA, the possession of less than 30 grams of cannabis or 1 gram of cannabis resin, would result in which of the following?
A.A summary conviction
B. An indictable offence
C. An indictable offence or a summary conviction
D. A criminal offence

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

 

 

12.                Under the CSDA, the possession of cannabis for the purpose of trafficking would result in which of the following?
A.A summary conviction
B. An indictable offence
C. An indictable offence or a summary conviction
D. A criminal record

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

13.                Which of the following amounts represents the least amount of grams required to result in a potential dual offence under CDSA?
A.25 grams
B. 30 grams
C. 35 grams
D. 40 grams

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

14.                Which of the following is an offence under the Controlled Drugs and Substances Act?
A.To obtain a controlled substance from a practitioner.
B. To obtain a controlled substance without a prescription.
C. To obtain a controlled substance without a license.
D. To obtain a controlled substance without revealing other controlled substances procured from other practitioners within a 30 day period.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

 

 

15.                Where are the offenses dealing with drug paraphernalia laws addressed in Canadian legislation?
A.Controlled Drugs and Substances Act.
B. Criminal Code of Canada.
C. In both the Controlled Drugs and Substances Act and Criminal Code of Canada.
D. Narcotic Control Act.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

16.                Under the CDSA it is an offence to seek or obtain a controlled substance from a medical practitioner without disclosing to that practitioner all other controlled substances obtained from other practitioners within the previous 30 days. What would be the maximum punishment for this offence?
A.Indictment is 1 years
B. Indictment is 3 years
C. Indictment is 7 years
D. Indictment is 10 years

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

17.                How is the synthetic drug LSD listed?
A.Schedule I
B. Schedule II
C. Schedule III
D. Class A

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

 

 

18.                Martin claims he was the first person to have his case heard in a drug treatment court in Canada. What city would this have taken place in?
A.Vancouver
B. Winnipeg
C. Toronto
D. Montreal

 

Accessibility: Keyboard Navigation
Bloom’s: Apply
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

19.                Richard claims he was the first person to have his case heard in a drug treatment court in Canada. In what year would his case have been heard?
A.1995
B. 1998
C. 2001
D. 2004

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

20.                How has the omnibus Bill S-10, been otherwise termed?
A.Safe School and Communities Act
B. Safe Streets and Communities Act
C. Safe Streets and Prisons Act
D. Safe Prisons and Streets Act

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

 

 

21.                In which year did Bill S-10 received Royal Assent and became law in Canada?
A.2011
B. 2012
C. 2013
D. 2014

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

22.                The amendments in Bill C-10 prescribe mandatory prison terms for offences related to drugs listed which of the following?
A.Schedule I
B. Schedule I and II
C. Schedule II and III
D. Schedule III

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

23.                Before a new drug is released into the Canadian market what does Health Canada’s HPFB require?
A.A pricing comparison with competing drugs.
B. Proof that no adverse reactions will occur.
C. The manufacturer of the drug to file a NDS.
D. Personal testimony from patients who have tried the drug.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

 

 

24.                With respect to regulating drugs in Canada, what is the responsibility of the provincial and territorial governmental bodies?
A.To oversee drug benefit programs for military personal.
B. To manage drug formularies.
C. To manage drug benefit programs for the RCMP.
D. To oversee drug benefit programs for Aboriginal Peoples.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

25.                In which decade in Canada did the government establish regulations on investigating new drug applications?
A.1940s
B. 1950s
C. 1960s
D. 1970s

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

26.                In 2004, Parliament passed the Jean Chretien Pledge to Africa Act. According to this act what can governments of WTO member countries grant?
A.A compulsory license for a generic medication, therapeutically equivalent to a brand name drug, without the consent of the patent holder.
B. Protection for pharmaceutical companies that would allow them sole license to market their drug on a worldwide basis.
C. Non-member countries the right to access free drugs if they need them.
D. Extended protection of patented medicines that are in demand worldwide.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

 

 

27.                What does the four phase process to approve drugs for use in Canada include?
A.Phase one: testing on animals.
B. Phases three and four: testing that occurs after approval.
C. Phase three: testing that takes place with healthy volunteers.
D. Phase four: testing that occurs after approval.

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

28.                Approximately how many pharmaceutical products are available on the Canadian market?
A.Less than 10,000
B. Between 10,000-15,000
C. Less than 20,000
D. More than 20,000

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-05 Discuss the pharmaceutical industry in Canada.

29.                Pharmaceutical sales in Canada account what percent of the global market?
A.1%
B. 2%
C. 3%
D. More 4%

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-05 Discuss the pharmaceutical industry in Canada.

 

 

30.                All of the following represent disorders that would allow legal access to marijuana under The Marihuana Medical Access Regulations EXCEPT which one?
A.Multiple sclerosis
B. Nausea due to HIV/AIDS
C. Anorexia
D. Diagnosed anxiety disorder

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

31.                In what year did Health Canada implement The Marihuana Medical Access Regulations?
A.1995
B. 2001
C. 2005
D. 2010

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

32.                Which of the following cases brought about the monumental legal decision that invalidated the marijuana prohibition under the CDSA?
A.R. v Emery
B. R. v Jackson
C. R. v Parker
D. R. v Smith

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

 

 

33.                When a Federal Court judge in Vancouver issued an injunction against the government’s plans to end the practice of grow-your-own medical marijuana what occurred?
A.It allowed the approximately 30,000 existing licenses for home-grown pot users/patients to continue growing their own.
B. It allowed for the continued use of medical marijuana, but the consumers had to buy “quality-controlled” marijuana from federally approved commercial producers.
C. It allowed the approximately 5,000 existing licenses for home-grown pot users/patients to continue growing their own.
D. It allowed the existing licences for home-grown pot users/patients to continue growing their own, but disallowed any further licences from going forward.

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

34.                Since the inception of the Marihuana Medical Access Program (MMAP), stakeholder concerns have grown. All of the following have been raised EXCEPT which one?
A.Potential for diversion of marijuana to illicit markets due to limited security requirements.
B. Increase potential for overdoes caused due to polysubstance use.
C. Risk of violent home invasion by criminals attempting to steal marijuana.
D. Creation of fire hazards resulting from faulty or overloaded electricity installations used to support marijuana cultivation.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

35.                Before what year in Canada were natural health products sold as either drugs or food under the Food and Drugs Act?
A.1990
B. 1995
C. 2000
D. 2004

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

 

36.                With respect to natural health products, which of the following statements represent the position Health Canada would state?
A.Health Canada is concerned only with ensuring their efficacy and safety, not their purity.
B. Health Canada is concerned only with ensuring their purity and safety, not their efficacy.
C. Health Canada is concerned only with ensuring their purity and efficacy, not their safety.
D. Health Canada is concerned with ensuring their purity, safety, and their efficacy.

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

37.                In which decade did officials at Health Canada become concerned with a rapidly growing market in natural health products (NHPs)?
A.1970s
B. 1980s
C. 1990s
D. 2000s

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

38.                Beginning in which year in Canada did all natural products with associated claims of health benefits became subject to the regulations of the NHPD?
A.1984
B. 1994
C. 2004
D. 2014

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

 

39.                From a pharmacological perspective, the word narcotic can only be correctly used to label which of the following?
A.Marijuana
B. Cocaine
C. Morphine
D. Ecstasy

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

True / False Questions

40.                Prior to 1928, Canada did not have regulations, federal or provincial, for governing the use of drugs.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

41.                Drug regulations in Canada were not driven by concerns for the health of its citizens but it had more to do with public fear of Chinese and Japanese immigrants.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

42.                In 1908, John A MacDonald travelled to British Columbia to gather information pertaining to the 1907 labour demonstrations and riots and the opium dens.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

 

 

43.                A former Winnipeg police officer, a member of the group Law Enforcement Against Prohibition Stated if police are suggesting tickets for possession less than 30 grams ( called a common offence) then prohibition should take place altogether.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

44.                The Controlled Drugs and Substances Act (CDSA) replaced the Narcotic Control Act and Parts III and IV of the Food and Drugs Act.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

45.                The sale and use of alcohol and tobacco is only subject to provincial/territorial legislation.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

46.                Winnipeg was the first city in Canada to implement a drug treatment court.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

 

 

47.                With the Royal Assent for Bill S-10 mandatory minimum jail sentences for marijuana offences became law.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

48.                The history of introducing new drugs into the marketplace in Canada can be traced back to the 1940s.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

49.                World Trade Organization countries may grant compulsory licensing to produce and sell generic drugs, which are therapeutically equivalent to their patented counterpart, under certain conditions.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

50.                In Canada Bill C-22 provides for a 20 year protection period for drug manufacturers beginning on the date that the patent is filed.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

 

 

51.                In, Canada Phase I testing of drugs is conducted using animal subjects only.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

52.                Canada is ranked 5^th in the world for its pharmaceutical sales.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-05 Discuss the pharmaceutical industry in Canada.

53.                If you are seeking to live in a country where Marijuana has received approval as a therapeutic drug you will find that Mexico is the only country that does.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

54.                On July 30, 2001, Health Canada implemented the MMAR, which clearly articulated the process through which access to marijuana for medical purposes was permitted.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

 

 

55.                The Supreme Court of Canada ruled the law prohibiting marijuana possession a violation of the Canadian Charter of Rights and Freedoms because it did not take users of medical marijuana into account.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

56.                Any person wishing to use marijuana for medicinal purposes in Canada under the Marihuana Medical Access Regulations, must provide a declaration from a medical practitioner.
TRUE

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

57.                The Food and Drug Act and Regulations drug manufacturers must prove that their drugs were an effective treatment for some diseases.
FALSE

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

 

 

Short Answer Questions

58.                Describe the Patent Medicine Act of 1909.

It was the first step toward federal drug regulation in Canada. This legislation required the documentation and approval of a small number of drugs formulated and issued by doctors. It also prohibited the use of cocaine in medicines.

 

Bloom’s: Remember
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

59.                When did the Le Dain Commission take place, and what was the outcome?

The inquiry took place between 1969 and 1973. The commission produced four reports.

 

Bloom’s: Understand
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

60.                Describe the scope of Sentencing under the Controlled Drugs and Substances Act (CDSA).

Under the CDSA judges are afforded considerable discretion in sentencing offenders. Aggravating factors that often influence sentencing decisions include the selling drugs to children, involving children under 18 years of age in the commission of an offence, or selling drugs in or near schools or public places frequented by youth.

 

Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

 

 

61.                What was one of the primary changes resulting from the enactment of Bill C-10?

It was an omnibus Bill that included amendments to Canada’s Controlled Drugs and Substances. With the Royal Assent for Bill S-10 mandatory minimum jail sentences for marijuana offences became law Act (CDSA).

 

Bloom’s: Understand
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

62.                Describe the Natural Health Products standards in Canada.

Ensuring the efficacy, safety, and quality of pharmaceutical drugs, vitamins, vaccines, and medical devices sold in Canada is the responsibility of Health Canada. Their mandate to provide this oversight is contained within the Food and Drugs Act and Regulations.

 

Bloom’s: Remember
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

63.                Describe The Compendium of Pharmaceuticals and Specialties.

The Compendium of Pharmaceuticals and Specialties (CPS) is published annually by the Canadian Pharmacists Association (CPhA) and has been providing health care professionals with a centralized source of Health Canada-approved product monographs since 1960.

 

Bloom’s: Understand
Learning Objective: 03-05 Discuss the pharmaceutical industry in Canada.

 

 

64.                Describe when the Canadian Marihuana Medical Access Regulations (MMAR) was enacted and its primary purpose.

On July 30, 2001, Health Canada implemented the MMAR, which clearly articulated the process through which access to marijuana for medical purposes was permitted. The Marihuana Medical Access Regulations (MMAR) provide a mechanism for patients to access marijuana for medical purposes with the support of their physician.

 

Bloom’s: Understand
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

65.                How does the Food and Drug Act and Regulations describe a drug?

According to the Food and Drug Act and Regulations, any substance “manufactured, sold or represented for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, in human beings or animals” is a drug.

 

Bloom’s: Understand
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

Essay Questions

66.                Describe the main reason an interest was generated to create The Opium Act of 1908.

In 1908, then Canadian Deputy Minister of Labour Mackenzie King travelled to British Columbia to gather information pertaining to the 1907 labour demonstrations and riots. During this visit King interviewed two Vancouver opium merchants, who revealed to him the extent to which opium was being traded and consumed in British Columbia. Based on these interviews, King drew four conclusions: (1) that opium smoking was growing in popularity among white people, (2) that Chinese merchants were making considerable profits through the opium trade, (3) that the opium trade was in violation of current provincial pharmacy legislation, and (4) that as a Christian nation, Canada had a moral responsibility to serve as a leader in the then international campaign against opium use.

 

Bloom’s: Understand
Learning Objective: 03-01 Summarize the history of and influences on the creation of drug regulations in Canada.

 

 

67.                Identify what Canadian legislation addresses Drug Paraphernalia Laws, and what is the scope of penalties.

Under section 462.2 of the Criminal Code of Canada the import, export, manufacturing, promoting, or selling of instruments or literature for illicit drug use is a summary conviction offence. The consequences of conviction are severe (e.g., for a first offence, to a fine not exceeding $100 000 or to imprisonment for a term not exceeding six months or both).

 

Bloom’s: Understand
Learning Objective: 03-02 Describe the Controlled Drugs and Substances Act.

68.                Describe Bill S-10, and the areas that highlight serious crime.

Bill S-10, otherwise known as the “Safe Streets and Communities Act,” was an omnibus Bill that included amendments to Canada’s Controlled Drugs and Substances Act (CDSA). It proposed minimum penalties for serious drug offences, such as dealing drugs for organized crime purposes or when a weapon or violence is involved.
Bill S-10 received Royal Assent and became law during the 41^st Parliament, which ended in September 2013. This law made jail time for serious drug offence convictions mandatory, and where “aggravating factors” are present such as: production; trafficking; possession for the purpose of trafficking or exporting and importing and exporting.

 

Bloom’s: Understand
Learning Objective: 03-03 Discuss Bill S-10 and its potential impacts.

69.                Give a brief description of the process required in Canada for a pharmaceutical company to test a new drug on humans and later to market a new prescription drug.

Animal testing must be followed by an CTA application to the HPFB of Health Canada, then three phases of clinical testing, which must also be approved by the HPFB as well as the Phase IV testing that takes place after approval. Bonus: an explanation of the BGTD’s role in the trials involving biological and radiopharmaceutical, including blood and blood products, tissue, genetic therapeutic product and vaccines both viral and bacterial.

 

Bloom’s: Analyze
Learning Objective: 03-04 Explain how pharmaceuticals are regulated in Canada.

 

 

70.                Give a brief description of the internet activity between Canada and the United States as it relates to pharmaceuticals.

Cross-border Internet pharmacy sales between Canada and the United States grew swiftly from 2000 to 2003, but have since progressively declined to 2% of total exports in 2011. The top ten pharmaceutical products sold in Canada account for 14% of 2012 industry sales. Leading therapeutic categories are neuro-therapies, cardiovascular, and gastrointestinal.

 

Bloom’s: Remember
Learning Objective: 03-05 Discuss the pharmaceutical industry in Canada.

71.                There are two categories under which Canadians can apply for medical marijuana under the Marihuana Medical Access Regulations. Explain the categories.

Category 1 includes pain and/or muscle spasm associated with multiple sclerosis or spinal cord injury or spinal cord disease. Category 1 also includes health issues associated with cancer treatment and end-of-life care for cancer and HIV/AIDS patients, as well as, for the relief of pain in severe forms of arthritis. People suffering from epileptic seizures may also apply to possess marijuana for medicinal purposes. Category 2 includes people who are suffering from debilitating medical conditions that are not included in Category 1 and for whom traditional treatments have proved ineffectual. Bonus: Applications under both categories must be accompanied by a declaration from a medical practitioner.

 

Bloom’s: Remember
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

72.                Describe the criteria and defining differences between Category 1 and 2 of the Marihuana Medical Access Regulations (MMAR).

Category 1 comprises any symptoms treated within the context of compassionate end-of life care or the symptoms associated with the specified medical conditions. Category 2 applies to persons who have debilitating symptoms of medical conditions other than those described in Category 1.

 

Bloom’s: Understand
Learning Objective: 03-06 Explain the Marihuana Medical Access Regulations (MMAR) of July 2001.
Learning Objective: 03-07 Discuss the Marihuana for Medical Purposes Regulations (MMPR) of April 2014.

 

 

73.                Why in the 1990s, did officials at Health Canada become concerned with a rapidly growing market in natural health products (NHPs)?

Officials at Health Canada became concerned with a rapidly growing market in natural
NHPs because the term NHP was used to represent a variety of substances that were being formulated, packaged, and/or promoted in a manner similar to drugs but that were classified and regulated as foods. These substances include vitamins and mineral supplements, herbal remedies (herb- and plant-based remedies), homeopathic medicines, traditional medicines such as traditional Chinese and Ayurvedic medicines, probiotics, amino acids, and essential fatty acids. Health Canada’s concerns lay in that fact that these natural products, while being promoted as therapeutic, were classified as foods.

 

Bloom’s: Understand
Learning Objective: 03-08 Describe how natural health products are regulated in Canada.

 

Chapter 05

The Actions of Drugs

 

 

Multiple Choice Questions

1.   Most of our drugs originally came either directly or indirectly from which of the following?
A.The sea
B. Plants
C. Animals
D. Chemists

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-01 Explain why plants are the source of many of the chemicals we use as drugs.
Learning Objective: 05-02 Distinguish among generic; brand; and chemical names for a drug.

2.   St. John’s wort is an herb that is believed to help what condition?
A.Anxiety
B. Depression
C. Arthritis
D. Congestive heart failure

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-01 Explain why plants are the source of many of the chemicals we use as drugs.
Learning Objective: 05-02 Distinguish among generic; brand; and chemical names for a drug.

 

 

3.   Which of the following provides an important distinction regarding the herb St. John’s wort?
A.It was first discovered to be a potent cardiotonic; it improved the heat’s pumping action.
B. Unlike other herbal supplements approved by the NHPR, it should only be taken under a doctor’s supervision.
C. If taken with other herbal supplements, an induced psychosis can occur.
D. When smoked is classified as a schedule 5 drug under the CSDA.

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-01 Explain why plants are the source of many of the chemicals we use as drugs.
Learning Objective: 05-02 Distinguish among generic; brand; and chemical names for a drug.

4.   Most drugs have three different kinds of names. Which one would identify the manufacturer?
A.Chemical name
B. Generic name
C. Brand name
D. Research name

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-02 Distinguish among generic; brand; and chemical names for a drug.

5.   What does the group of psychoactive drugs called stimulants include?
A.Cocaine
B. Prozac
C. LSD
D. Heroin

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-03 Name the major drug categories.

 

 

6.   Among the psychoactive drugs, how is alcohol classified?
A.Stimulant
B. Opioid
C. Hallucinogen
D. Depressant

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-03 Name the major drug categories.

7.   In addition to ADHD, which individual may also be prescribed Ritalin?
A.Josh who has difficulty sleeping.
B. Martin who has a mild case of congestive heart failure.
C. Sarah who has a spider phobia preventing her from attending school.
D. Diane who frequently falls asleep at work, and has been known to fall asleep while driving.

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-03 Name the major drug categories.

8.   How many children did Health Canada estimate are taking Ritalin in Canada?
A.45,000
B. 100,000
C. 145,000
D. 255,000

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-03 Name the major drug categories.

 

 

9.   Based on the significant increase of prescription amphetamines use by Canadian university students, what did Maclean’s magazine call Ritalin?
A.”The Get Smart Pill”
B. “The Go All Night Pill”
C. “Concentration for $5 a pill”
D. “The Student pill for success”

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-03 Name the major drug categories.

10.                Alcohol and inhalants are all examples of which drug grouping?
A.Hallucinogens
B. Analgesics
C. Psychotherapeutics
D. CNS Depressants

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-03 Name the major drug categories.

11.                Prozac and thorazine are examples of which drug grouping?
A.Hallucinogens
B. Analgesics
C. Psychotherapeutics
D. CNS Depressants

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-03 Name the major drug categories.

 

 

12.                Mescaline, ecstasy, and cannabis are examples of which drug grouping?
A.Hallucinogens
B. Analgesics
C. Psychotherapeutics
D. CNS Depressants

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-03 Name the major drug categories.

13.                LSD and PCP are examples of which drug grouping?
A.Hallucinogens
B. Analgesics
C. Psychotherapeutics
D. CNS Depressants

 

Accessibility: Keyboard Navigation
Bloom’s: Understand
Learning Objective: 05-03 Name the major drug categories.

14.                Which of these is difficult to classify, due to its complex effects at different doses?
A.Cocaine
B. Marijuana
C. Prozac
D. Caffeine

 

Accessibility: Keyboard Navigation
Bloom’s: Remember
Learning Objective: 05-03 Name the major drug categories.